MicroRNA‐575 targets BLID to promote growth and invasion of non‐small cell lung cancer cells
暂无分享,去创建一个
Chunhua Yan | Hongwei Wang | Chunhua Yan | Lei Yang | Hongwei Wang | Lili Deng | Xiaodong Shi | Jiaolin Zheng | Lei Yang | Fangfei Yu | Yuandi Yang | Yuxia Shao | Xiaodong Shi | L. Deng | Y. Shao | Jiaolin Zheng | F. Yu | Yuandi Yang
[1] F. Boccardo,et al. Role of microRNAs in malignant mesothelioma , 2014, Cellular and Molecular Life Sciences.
[2] A. Noone,et al. Frequent Loss of the BLID Gene in Early-Onset Breast Cancer , 2011, Cytogenetic and Genome Research.
[3] L. Goedeke,et al. MicroRNAs in metabolic disease. , 2013, Arteriosclerosis, thrombosis, and vascular biology.
[4] L. Pastore,et al. Characterization and predicted role of the microRNA expression profile in amnion from obese pregnant women , 2014, International Journal of Obesity.
[5] Hui Gu,et al. Diagnostic role of microRNA expression profile in the serum of pregnant women with fetuses with neural tube defects , 2012, Journal of neurochemistry.
[6] Weixiang Shi,et al. Gene expression analysis of lung cancer. , 2014, European review for medical and pharmacological sciences.
[7] C. Fernández-Hernando,et al. MicroRNA Regulation of Cholesterol Metabolism , 2012, Cholesterol.
[8] Zhangsuo Liu,et al. miR-96 downregulates RECK to promote growth and motility of non-small cell lung cancer cells , 2014, Molecular and Cellular Biochemistry.
[9] Xiaoyan Li,et al. Aberrant BLID expression is associated with breast cancer progression , 2014, Tumor Biology.
[10] Changqing Zeng,et al. Evaluation of BLID and LOC399959 as candidate genes for high myopia in the Chinese Han population , 2010, Molecular vision.
[11] Hong Yu,et al. miR‐138 inhibits proliferation by targeting 3‐phosphoinositide‐dependent protein kinase‐1 in non‐small cell lung cancer cells , 2015, The clinical respiratory journal.
[12] S. H. Najafi-Shoushtari. MicroRNAs in Cardiometabolic Disease , 2011, Current atherosclerosis reports.
[13] B. Han,et al. Molecular signatures in response to Isoliquiritigenin in lymphoblastoid cell lines. , 2012, Biochemical and biophysical research communications.
[14] Chen Huang,et al. MicroRNA profiling of human gastric cancer. , 2009, Molecular medicine reports.
[15] Shi Wy,et al. Gene expression analysis of lung cancer. , 2014 .
[16] G. Dy,et al. Targeted therapies in development for non-small cell lung cancer , 2013, Journal of carcinogenesis.
[17] R. Gerszten,et al. MicroRNAs in metabolism and metabolic diseases. , 2011, Cold Spring Harbor symposia on quantitative biology.
[18] Yanyan Huang,et al. An Integrated Analysis of miRNA and mRNA Expressions in Non-Small Cell Lung Cancers , 2011, PloS one.
[19] Lin Jiang,et al. Decreased circulating miR-375: A potential biomarker for patients with non-small-cell lung cancer. , 2014, Gene.
[20] T. Yoshimoto,et al. A Homeobox Protein, Prox1, Is Involved in the Differentiation, Proliferation, and Prognosis in Hepatocellular Carcinoma , 2006, Clinical Cancer Research.
[21] Thomas Kirchner,et al. p53-induced miR-15a/16-1 and AP4 form a double-negative feedback loop to regulate epithelial-mesenchymal transition and metastasis in colorectal cancer. , 2014, Cancer research.
[22] T. Liloglou,et al. Epigenetic biomarkers in lung cancer. , 2014, Cancer letters.
[23] L. Hawthorn,et al. WASF3 regulates miR-200 inactivation by ZEB1 through suppression of KISS1 leading to increased invasiveness in breast cancer cells , 2013, Oncogene.
[24] M. Ferracin,et al. MicroRNA expression changes during human leukemic HL-60 cell differentiation induced by 4-hydroxynonenal, a product of lipid peroxidation. , 2009, Free radical biology & medicine.
[25] H. Guan,et al. MiR‐503 targets PI3K p85 and IKK‐β and suppresses progression of non‐small cell lung cancer , 2014, International journal of cancer.
[26] Tao Yang,et al. MicroRNA-490-3p inhibits proliferation of A549 lung cancer cells by targeting CCND1. , 2014, Biochemical and biophysical research communications.
[27] Tao Yu,et al. MicroRNA-193a-3p and -5p suppress the metastasis of human non-small-cell lung cancer by downregulating the ERBB4/PIK3R3/mTOR/S6K2 signaling pathway , 2014, Oncogene.
[28] H. Horvitz,et al. MicroRNA expression profiles classify human cancers , 2005, Nature.
[29] X. Li,et al. BRCC2 inhibits breast cancer cell growth and metastasis in vitro and in vivo via downregulating AKT pathway , 2013, Cell Death and Disease.
[30] A. Dritschilo,et al. BRCC2, a Novel BH3-like Domain-containing Protein, Induces Apoptosis in a Caspase-dependent Manner*[boxs] , 2004, Journal of Biological Chemistry.
[31] X. Bian,et al. The putative tumour suppressor microRNA-124 modulates hepatocellular carcinoma cell aggressiveness by repressing ROCK2 and EZH2 , 2011, Gut.